Ideas move faster when research, healthcare and community come together
In the Hunter region of New South Wales, six medical researchers have been selected for a structured fellowship program that pairs scientific ambition with practical mentoring and meaningful funding. Their work — spanning infant respiratory care, childhood cancer navigation, precision oncology, AI-assisted wound care, radiation-free lung imaging, and genomic analysis — reflects a broader recognition that good ideas require more than a laboratory to become real solutions. The Newcastle Permanent Innovators Program, now in its second year, represents a quiet but deliberate investment in the belief that the people closest to a region's health problems are often best placed to solve them.
- Vulnerable patients — newborns with breathing difficulties, children with cancer, adults with chronic lung disease — are waiting on research that hasn't yet made it out of the lab and into the clinic.
- Six early and mid-career researchers are racing to close that gap, each building something tangible: a platform, a protocol, an imaging method, a decision-support tool.
- The program compresses months of development into six intensive weeks of workshops, mentoring, and community engagement designed to stress-test assumptions before they harden into costly mistakes.
- Two researchers will receive $100,000 fellowships and four will receive $20,000 seed grants — real resources attached to real accountability, culminating in a public pitch event in August.
- The partnership between HMRI and Newcastle Permanent signals that translating research into care requires not just scientific talent but sustained institutional commitment from beyond the hospital walls.
Six researchers from across the Hunter region's hospitals and universities have been selected for the Newcastle Permanent Innovators Program — a competitive, six-week initiative run by the Hunter Medical Research Institute that pairs early and mid-career scientists with mentors, structured workshops, and substantial funding. Two will receive $100,000 fellowships; four will receive $20,000 seed grants. The cohort will present their work at a public pitch event in August.
The health challenges they're addressing are wide-ranging but share a common thread: they affect people at their most vulnerable. Dr Gabriela Martins Costa Gomes is working on earlier detection of breathing problems in newborns, while Dr Geshani Jayasuriya is developing lung imaging that eliminates the need for radiation — a meaningful safety gain for patients who require repeated monitoring. Both sit within HMRI's Breathing and Lung Health Research Program.
On the cancer front, Dr Meg Lim is building a digital platform to help families quickly find financial assistance and support services after a child's diagnosis — resources that already exist but are scattered and difficult to navigate. Dr Heather Murray is taking a different angle, researching how to match patients with treatments suited to their specific tumor biology rather than relying on standardized protocols.
The remaining two researchers are laying groundwork for medicine's future. Dr Stuart Szwec is applying artificial intelligence to wound care, helping clinicians choose dressings more accurately and reduce the delays that come from trial and error. Dr Alexandre Xavier is creating an online platform for analyzing genetic data, giving researchers and clinical teams the tools to translate growing volumes of genomic information into personalized treatment decisions.
HMRI CEO Frances Kay described the program as a deliberate effort to support researchers who understand that science must engage with the real world to matter. Newcastle Permanent's Paul Juergens echoed that framing, emphasizing the value of investing in local talent equipped to address local problems. What distinguishes this cohort is not just the quality of their ideas, but their shared orientation: they are building things meant to be used — and the program is designed to hold them accountable to that ambition.
Six researchers working across the Hunter region's hospitals and universities have been chosen for a competitive program that pairs them with mentors, workshops, and substantial funding to move their early-stage health ideas toward real patients. The Newcastle Permanent Innovators Program, now in its second year, is run by Hunter Medical Research Institute in partnership with the local financial institution. Over six weeks, the cohort will work through a structured process designed to test their assumptions, engage with communities affected by the problems they're trying to solve, and build the practical skills needed to turn laboratory insights into working solutions. Two of the six will walk away with $100,000 fellowships each. The other four will receive $20,000 seed grants. The program culminates in August with a public pitch event.
The health challenges they're tackling span the full spectrum of what makes the region's medical system strain. Dr Gabriela Martins Costa Gomes, a paediatric respiratory physician, is working on earlier detection of breathing problems in newborns—the kind of intervention that can reshape a child's entire trajectory if caught in time. Dr Geshani Jayasuriya is designing lung imaging that doesn't require radiation, a significant safety gain for children and adults who need repeated monitoring of airway disease. Both researchers work within HMRI's Breathing and Lung Health Research Program, addressing a category of illness that affects vulnerable populations across the lifespan.
The cancer work takes two forms. Dr Meg Lim, a health economist, is building a digital platform to help families navigate the financial chaos that erupts when a child is diagnosed with cancer—connecting them quickly to assistance programs and support services that already exist but are scattered and hard to find. Dr Heather Murray is approaching the disease itself differently, researching how to match individual patients with the cancer treatments most likely to work for their specific tumor biology, moving away from one-size-fits-all protocols toward precision matching.
The remaining two researchers are building infrastructure for the future of medicine. Dr Stuart Szwec is developing artificial intelligence to help clinicians select wound dressings faster and more accurately, improving healing outcomes and reducing the trial-and-error that can delay recovery. Dr Alexandre Xavier is creating an online platform for analyzing genetic data—the kind of tool that researchers and clinical teams need to make sense of the growing volume of genomic information and translate it into personalized treatment decisions.
Frances Kay, the CEO and Institute Director of HMRI, frames the program as a deliberate effort to support the next generation of researchers who understand that good science requires engagement with the real world. "When research, healthcare and community come together, we create the conditions for ideas to move faster towards real-world impact," she said. Paul Juergens, speaking for Newcastle Permanent, emphasized that backing healthcare outcomes means investing in local talent and ideas—the kind of commitment that requires sustained funding and institutional patience. The program reflects a belief that the best solutions to regional health problems often come from people embedded in those regions, who understand the constraints and the communities they serve.
The six researchers represent a mix of career stages and disciplinary approaches, but they share a common orientation: they're not content to publish findings and move on. They're building things—platforms, imaging protocols, detection methods, decision-support tools—that are meant to be used. The August pitch event will be the first public test of how far they've come in translating their ideas into something that could actually change how care is delivered. What happens after that—whether the funding leads to further development, whether the prototypes find their way into hospitals and clinics—will depend on factors beyond the program itself. But the structure is in place to give these six researchers the mentoring, the resources, and the accountability to move their work from promising to practical.
Notable Quotes
When research, healthcare and community come together, we create the conditions for ideas to move faster towards real-world impact.— Professor Frances Kay, HMRI CEO and Institute Director
Supporting the long-term wellbeing of the regions we serve is an important part of who we are at Newcastle Permanent, and this program helps promising local ideas to move closer to positive impact.— Paul Juergens, Newcastle Permanent spokesperson
The Hearth Conversation Another angle on the story
Why does a financial institution like Newcastle Permanent care about funding medical research? That seems like an unusual partnership.
It's not as unusual as it might seem. Newcastle Permanent is a mutual organization—it's owned by its members, not shareholders. That means the institution's long-term health is tied directly to the health of the communities it serves. Healthier communities are more economically stable, more productive, less burdened by preventable illness. It's enlightened self-interest, but it's also genuine commitment.
So these six researchers—they're not getting a blank check. They're being asked to prove something in six weeks?
Exactly. The program is structured around a specific process: understand the problem, engage with the people affected by it, develop a practical solution, and build the skills to move it forward. It's not just about the money. It's about learning how to translate research into something that actually works in the real world.
What makes this different from just giving researchers a grant and letting them work?
The mentoring and the community engagement piece. A lot of brilliant researchers can get stuck in the lab, solving elegant problems that don't quite fit how healthcare actually works. This program forces them to step outside, talk to patients and clinicians, understand the constraints they're working within. That changes what you build.
Two of them get $100,000 and four get $20,000. How do they decide who gets what?
That happens at the August pitch event. They present their work to judges who evaluate not just the science but the feasibility, the potential impact, the clarity of the plan to move forward. It's competitive, but it's also transparent.
What happens if someone's idea doesn't work out?
The seed grants are meant to be starting points. Even if the initial idea doesn't pan out exactly as planned, the researcher has learned something, built relationships, and has a clearer picture of what the next step should be. That's valuable in its own right.